1. Home
  2. MFIC vs NBTX Comparison

MFIC vs NBTX Comparison

Compare MFIC & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MidCap Financial Investment Corporation

MFIC

MidCap Financial Investment Corporation

HOLD

Current Price

$10.32

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$32.78

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFIC
NBTX
Founded
2004
2003
Country
United States
France
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MFIC
NBTX
Price
$10.32
$32.78
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$11.46
$26.00
AVG Volume (30 Days)
1.2M
39.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
11.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$11.73
P/E Ratio
$10.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.48
$2.99
52 Week High
$13.51
$41.89

Technical Indicators

Market Signals
Indicator
MFIC
NBTX
Relative Strength Index (RSI) 43.08 57.18
Support Level $9.48 $20.11
Resistance Level $11.74 N/A
Average True Range (ATR) 0.40 2.69
MACD -0.00 0.03
Stochastic Oscillator 57.09 47.72

Price Performance

Historical Comparison
MFIC
NBTX

About MFIC MidCap Financial Investment Corporation

MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: